Tekrardan Hoşgeldiniz
Cointime’a Katıl
Giriş Yap
Kayıt Ol
Gelen kutunuzu kontrol edin
Malin Corporation
About
Malin Corporation plc is an Irish incorporated public limited company whose head office is in Dublin.
- Dublin,Dublin,Ireland
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €50M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Malin Corporation Plc
- Investor Type
- Venture Capital
Malin Corporation plc (“Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with subsidiary offices in New Haven, Connecticut and Research Triangle, North Carolina, USA.Malin’s purpose is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition and to achieve commercial success.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 1, 2015 | Series Unknown | €50M | 1 |
Ireland Strategic Investment Fund
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 15, 2022
CG Oncology
|
Series E | $120M | Biotechnology | — |
|
Apr 22, 2019
Poseida Therapeutics
|
Series C | $142M | Biopharma | — |
|
Apr 3, 2018
Poseida Therapeutics
|
Series B | $30.50M | Biopharma | — |
|
Aug 2, 2017
Poseida Therapeutics
|
Series A | $11.16M | Biopharma | Yes |
|
Feb 24, 2017
Xenex
|
Series Unknown | $38M | Health Care | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Ireland Strategic Investment Fund
|
Yes | Series Unknown |
Employee Profiles
Exits
Malin Corporation has had 5 exits. Malin Corporation most notable exits include Kymab , Poseida Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 11, 2021 | Kymab | M&A | Biopharma | Detail |
| Jul 9, 2020 | Poseida Therapeutics | IPO | Biopharma | Detail |
| Nov 27, 2019 | 3D4Medical.com | M&A | 3D Technology | Detail |
| Nov 6, 2017 | Melinta Therapeutics | M&A | Biotechnology | Detail |
| Sep 21, 2016 | Novan | IPO | Biotechnology | Detail |
Acquisition
Malin Corporation has acquired 2 organizations. Their most recent acquisition was Altan Pharma on Jun 11, 2015. They acquired Altan Pharma for €34.50M.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Jun 11, 2015
Altan Pharma
|
Biotechnology | acquisition | € 34.50M | Detail |
|
Jan 4, 2017
Cilatus BioPharma
|
Biotechnology | acquisition | — | Detail |
